Package 65862-027-10

{"route": ["ORAL"], "spl_id": "0f465f42-d781-453e-ac8c-f5017bf06fe1", "openfda": {"nui": ["N0000175463", "N0000175460", "N0000009948", "N0000190118", "N0000187064"], "unii": ["99DK7FVK1H"], "rxcui": ["199422"], "spl_set_id": ["5f6c3eed-2a5d-46ed-9a7c-59715f338a15"], "pharm_class_epc": ["Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]"], "manufacturer_name": ["Aurobindo Pharma Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "6 BLISTER PACK in 1 CARTON (65862-027-10)  / 10 TABLET in 1 BLISTER PACK", "package_ndc": "65862-027-10", "marketing_start_date": "20120522"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (65862-027-60)", "package_ndc": "65862-027-60", "marketing_start_date": "20120522"}], "brand_name": "Nevirapine", "product_id": "65862-027_0f465f42-d781-453e-ac8c-f5017bf06fe1", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Non-Nucleoside Analog [EXT]", "Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "65862-027", "generic_name": "Nevirapine", "labeler_name": "Aurobindo Pharma Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Nevirapine", "active_ingredients": [{"name": "NEVIRAPINE", "strength": "200 mg/1"}], "application_number": "ANDA077521", "marketing_category": "ANDA", "marketing_start_date": "20120522", "listing_expiration_date": "20261231"}